These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23271773)

  • 1. Improving the communication of benefits and harms of treatment strategies: decision AIDS for localized prostate cancer treatment decisions.
    Hoffman RM
    J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):197-201. PubMed ID: 23271773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presenting treatment options to men with clinically localized prostate cancer: the acceptability of active surveillance/monitoring.
    Donovan JL
    J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):191-6. PubMed ID: 23271772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The comparative effectiveness of decision aids in diverse populations with early stage prostate cancer: a study protocol for a cluster-randomized controlled trial in the NCI Community Oncology Research Program (NCORP), Alliance A191402CD.
    Pacyna JE; Kim S; Yost K; Sedlacek H; Petereit D; Kaur J; Rapkin B; Grubb R; Paskett E; Chang GJ; Sloan J; Basch E; Major B; Novotny P; Taylor J; Buckner J; Parsons JK; Morris M; Tilburt JC
    BMC Cancer; 2018 Aug; 18(1):788. PubMed ID: 30081846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis.
    Hayes JH; Ollendorf DA; Pearson SD; Barry MJ; Kantoff PW; Stewart ST; Bhatnagar V; Sweeney CJ; Stahl JE; McMahon PM
    JAMA; 2010 Dec; 304(21):2373-80. PubMed ID: 21119084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Informed Decision Making: Assessment of the Quality of Physician Communication about Prostate Cancer Diagnosis and Treatment.
    Holmes-Rovner M; Montgomery JS; Rovner DR; Scherer LD; Whitfield J; Kahn VC; Merkle EC; Ubel PA; Fagerlin A
    Med Decis Making; 2015 Nov; 35(8):999-1009. PubMed ID: 26304063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of a CDC Public Health Research Agenda for Low-Risk Prostate Cancer.
    Hall IJ; Lee Smith J
    Am J Prev Med; 2015 Dec; 49(6 Suppl 5):S483-8. PubMed ID: 26590643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clarifying uncertainty regarding detection and treatment of early-stage prostate cancer.
    Wilt TJ
    Semin Urol Oncol; 2002 Feb; 20(1):10-7. PubMed ID: 11828353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life in men undergoing active surveillance for localized prostate cancer.
    Bergman J; Litwin MS
    J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):242-9. PubMed ID: 23271780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient decision aids for prostate cancer treatment: a systematic review of the literature.
    Lin GA; Aaronson DS; Knight SJ; Carroll PR; Dudley RA
    CA Cancer J Clin; 2009; 59(6):379-90. PubMed ID: 19841280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient and family communication during consultation visits: The effects of a decision aid for treatment decision-making for localized prostate cancer.
    Song L; Tyler C; Clayton MF; Rodgiriguez-Rassi E; Hill L; Bai J; Pruthi R; Bailey DE
    Patient Educ Couns; 2017 Feb; 100(2):267-275. PubMed ID: 27692491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional, provider, and economic factors associated with the choice of active surveillance in the treatment of men with localized prostate cancer.
    Hamilton AS; Wu XC; Lipscomb J; Fleming ST; Lo M; Wang D; Goodman M; Ho A; Owen JB; Rao C; German RR
    J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):213-20. PubMed ID: 23271776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decision aids for people facing health treatment or screening decisions.
    Stacey D; Légaré F; Col NF; Bennett CL; Barry MJ; Eden KB; Holmes-Rovner M; Llewellyn-Thomas H; Lyddiatt A; Thomson R; Trevena L; Wu JH
    Cochrane Database Syst Rev; 2014 Jan; (1):CD001431. PubMed ID: 24470076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic Review of Decision Aids for Newly Diagnosed Patients with Prostate Cancer Making Treatment Decisions.
    Adsul P; Wray R; Spradling K; Darwish O; Weaver N; Siddiqui S
    J Urol; 2015 Nov; 194(5):1247-52. PubMed ID: 26055824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient perspective on watchful waiting/active surveillance for localized prostate cancer.
    Xu J; Neale AV; Dailey RK; Eggly S; Schwartz KL
    J Am Board Fam Med; 2012; 25(6):763-70. PubMed ID: 23136314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-based patient choice: a prostate cancer decision aid in plain language.
    Holmes-Rovner M; Stableford S; Fagerlin A; Wei JT; Dunn RL; Ohene-Frempong J; Kelly-Blake K; Rovner DR
    BMC Med Inform Decis Mak; 2005 Jun; 5():16. PubMed ID: 15963238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Decision Aid to Support Informed Choices for Patients Recently Diagnosed With Prostate Cancer: A Randomized Controlled Trial.
    Chabrera C; Zabalegui A; Bonet M; Caro M; Areal J; González JR; Font A
    Cancer Nurs; 2015; 38(3):E42-50. PubMed ID: 25010250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing a decision aid to support informed choices for newly diagnosed patients with localized prostate cancer.
    Chabrera C; Font A; Caro M; Areal J; Zabalegui A
    Cancer Nurs; 2015; 38(1):E55-60. PubMed ID: 24831045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing patients' acceptance and adherence to active surveillance.
    Penson DF
    J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):207-12. PubMed ID: 23271775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary Care Providers' Intended Use of Decision Aids for Prostate-Specific Antigen Testing for Prostate Cancer Screening.
    Rim SH; Hall IJ; Massetti GM; Thomas CC; Li J; Richardson LC
    J Cancer Educ; 2019 Aug; 34(4):666-670. PubMed ID: 29582364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.